Palliative treatment
194 results
1 - 100
Pharmacological treatments for fatigue associated with palliative care- Droperidol for treatment of nausea and vomiting in palliative care patients
- Haloperidol for the treatment of nausea and vomiting in palliative care patients
- Palliative drug treatments for breathlessness in cystic fibrosis
- Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours
- Psychosocial interventions for fatigue during cancer treatment with palliative intent
- Doxorubicin‐based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
- Early palliative care for adults with advanced cancer
- Palliative care interventions for people with multiple sclerosis
- Interventions for palliative symptom control in COVID‐19 patients
- Resection versus other treatments for locally advanced pancreatic cancer
- Medically assisted nutrition for adult palliative care patients
- Palliative chemotherapy for advanced or metastatic colorectal cancer
- Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- Levomepromazine for nausea and vomiting in palliative care
- Laxatives for the management of constipation in people receiving palliative care
- Pharmacological interventions for pruritus in adult palliative care patients
- Drug therapy for symptoms associated with anxiety in adult palliative care patients
- Palliative interventions for controlling vaginal bleeding in advanced cervical cancer
- Palliative care interventions in advanced dementia
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Palliative pharmacological sedation for terminally ill adults
- Palliative surgery versus medical management for bowel obstruction in ovarian cancer
- The effectiveness and cost‐effectiveness of hospital‐based specialist palliative care for adults with advanced illness and their caregivers
- Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving palliative care
- Palliative biliary stents for obstructing pancreatic carcinoma
- Oral versus intravenous fluoropyrimidines for colorectal cancer
- Radiofrequency ablation in the treatment of liver metastases from colorectal cancer: Cochrane systematic review
- Medically assisted hydration for adults receiving palliative care
- Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
- Chemotherapy for advanced gastric cancer
- Supportive care for patients with gastrointestinal cancer: Cochrane systematic review
- Transdermal fentanyl for cancer pain
- Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
- Interventions for dysphagia in oesophageal cancer
- Radical multimodality therapy for malignant pleural mesothelioma
- Megestrol acetate for treatment of anorexia‐cachexia syndrome
- Mistletoe extracts for cancer treatment
- Multidisciplinary rehabilitation after primary brain tumour treatment
- Adjuvant progestagens for endometrial cancer
- Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
- Bisphosphonates in multiple myeloma: an updated network meta‐analysis
- Chemotherapy for hormone‐refractory prostate cancer
- Psychostimulants for depression
- Antipsychotics for treatment of delirium in hospitalised non‐ICU patients
- Advance care planning for adults with heart failure
- Thermotherapy for treating rheumatoid arthritis
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
- Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer
- Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases